Market Dynamics The emphysema market is poised to experience a strong compound annual growth rate (CAGR) in terms of revenue during the forecast period. The growth in market revenue is primarily attributed to factors such as the increasing prevalence of respiratory diseases, including chronic bronchitis and emphysema. Additionally, there is a significant demand for treatment options like smoking cessation medications and antibiotics, which further fuels the growth of the emphysema market.
Key Market Trends and Innovations
- There is a growing trend toward novel drug therapies in emphysema treatment, including biologics and drug combinations.
- Clinical trials have been conducted on biologic drugs like GLASSIA and Zemaira, as well as a molecule named G8W15SF, to evaluate their efficacy in treating Chronic Obstructive Pulmonary Disease (COPD) and emphysema.
- Researchers at NUS Biological Sciences have identified a protein named isthmin 1 with potential in developing biologics for treating COPD, including emphysema.
Organic and Inorganic Strategies
- On March 15, 2022, the US Food and Drug Administration approved the first generic version of Symbicort, which is a drug-device formulation designed to reduce exacerbations in COPD, including emphysema.
According to the World Health Organization, the global population suffering from Chronic Obstructive Pulmonary Disease (COPD), often caused by factors like urbanization and cigarette smoking, stands at nearly 210 million individuals.
Emphysema is a condition that results in shortness of breath and damages the alveoli. Over time, it leads to the rupture of the inner walls of air sacs, reducing the surface area of the lungs, thereby decreasing the amount of oxygen entering the bloodstream.
Get a sample copy of the Emphysema Market report: https://www.reportsanddata.com/download-free-sample/5353
Key Factors Supporting Market Growth Drivers
- Regular cigarette smoking is a major contributor to the growth of the emphysema market. A study by the American Lung Association (ALA) found that smoking cigarettes alone was responsible for 85% to 90% of all chronic obstructive lung illnesses (COPDs) in 2019.
- The increasing prevalence of emphysema and exposure to air pollutants, dust, and chemical fumes are driving market growth. Approximately 14 million people are affected by emphysema in the United States.
Restraints
- High drug approval costs and low awareness of the disease are significant factors restraining the growth of the emphysema market. Additionally, the side effects and risks associated with emphysema drugs are expected to hamper market growth.
Opportunities
- The demand for novel drug therapies with fewer side effects and the development of combination and new treatments present substantial opportunities for the growth of the emphysema market.
Largest Market Share The North America market is expected to hold the highest share of revenue during the forecast period, as emphysema is prevalent in most countries in North America. The growth in this region is driven by factors such as an increase in the number of smokers, an aging population, demand for advanced treatments, the establishment of healthcare facilities, and increased government funding.
Fastest Growing Region The Asia Pacific region is anticipated to grow at the fastest rate during the forecast period, primarily due to increased investments by market players, rising healthcare expenditure, a surge in cigarette smokers, escalating pollution levels, and a growing geriatric population. Furthermore, the increasing prevalence of smoking and stressful lifestyles are likely to contribute to the incidence of emphysema in this region.
What Our Report Provides and Why Our Offering Is Superior This report offers historical data, forecasts, and revenue growth analysis at the global, regional, and country levels, along with insights into industry trends and consumption patterns for each region, major country, and segment from 2019 to 2030. The global market report covers industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and revenue share contributions from each regional and country market. Additionally, the report provides industry analysis, competitive landscape, company financials, and impact analysis.
Major Companies in the Market Include
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline plc
- Novartis International AG
- AstraZeneca
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Merck & Co.
- 3M
- Intersect ENT
- Apotex Inc.
- Amneal Pharmaceuticals LLC.
- Mylan N.V
- OptiNose US Inc.
Disease Type Outlook:
- Centriacinar
- Paracinar
- Paraseptal
- Others
Treatment Type Outlook:
- Bronchodilators
- Corticosteroids
- Antibiotics
- Others
Route of Administration Outlook:
- Oral
- Nasal
Product Outlook:
- Tablet
- Capsule
- Inhalers
Distribution Channel Outlook:
- Online
- Offline
End-Users Outlook:
- Hospitals
- Clinics
Region Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Spain, Sweden, BENELUX, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Rest of APAC)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, UAE, South Africa, Israel, Rest of MEA)
Explore Trending Reports:
Natural Food Colors Market-https://www.globenewswire.com/news-release/2020/08/25/2083402/0/en/Natural-Food-Colors-Market-To-Reach-USD-2-76-Billion-By-2027-Reports-and-Data.html
Sorbitol Market-https://www.globenewswire.com/fr/news-release/2020/02/12/1984072/0/en/Sorbitol-Market-To-Reach-USD-2-18-Billion-By-2027-Reports-And-Data.html
Probiotic Ingredients Market-https://www.globenewswire.com/en/news-release/2021/01/21/2162435/0/en/Probiotic-Ingredients-Market-To-Reach-USD-497-0-Million-By-2027-Growing-Awareness-and-Demand-for-Immunity-Boosting-Food-Products-are-Expected-to-Drive-Market-Growth-says-Reports-an.html
Protein Hydrolysate Market-https://www.globenewswire.com/news-release/2019/03/26/1768589/0/en/Protein-Hydrolysate-Market-To-Reach-USD-1013-2-Million-By-2026-Reports-And-Data.html
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/5353
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
